Abbott Pharmaceuticals recently pulled Meridia (Sibutramine) from the market. For years, they refused to run efficacy trials to confirm its use for the treatment of fibromyalgia, post-traumatic stress disorder, reflex sympathetic dystrophy, and myriad other diseases. Below is a series of documents demonstrating this.
13 years ago
